INSANE: 5 | Vintage Vibes

3 Near-oversold Dividend Aristocrats To Buy Before They Pop

These three Dividend Aristocrats trade near oversold levels and offer reliable income and potential capital appreciation.

Barchart · May 21, 2024

Medical device companies pay millions to NHS while pushing products, says study

Pharmaceutical equipment firms are funding NHS staff and training while promoting sales

The Guardian - UK · Apr 21, 2024

Abbott Exceeds Profit Expectations With Strong Medical Device Sales

Abbott Laboratories surpasses profit expectations with strong medical device sales, showcasing market leadership and growth strategies.

Top News · Apr 17, 2024

100 Years of Paying Dividends: Why You Need This Healthcare Stock

Dividend growth investors love this boring healthcare stock for three reasons: Growth, financial stability, and 100 years of paying dividends.

Barchart · Dec 19, 2023

Stocks Close Lower on Heightened Geopolitical Risks and Soaring Bond Yields

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.98%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.41%. Stocks on Wednesday closed sharply lower, with the...

Barchart · Oct 18, 2023

Abbott Laboratories (ABT) Earnings Insights: Will the Medical Stock Build Investor Confidence?

Considering Abbott Laboratories' (ABT) recent strategic collaborations and acquisitions to boost the company’s long-term growth, could the stock be a compelling buy as we approach its fiscal third-quarter earnings release? Let's find out.

StockNews.com · Oct 17, 2023

Worried About a Recession? Protect Your Portfolio With These 3 Resilient Stocks

With geopolitical tensions rising, here are three stocks from different sectors that have the ability to weather this storm.

Barchart · Oct 10, 2023

Building Wealth with Spinoffs: How Adding These Gems Can Transform Your Portfolio

Spinoffs are value creating investment opportunities. You should be looking at them

Barchart · Aug 31, 2023

Abbott’s COVID-19 test sales dive by nearly 90%

Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on from the pandemic.

Chicago Tribune · Jul 20, 2023

Humira, the world’s top-selling drug, faces an upcoming test from low cost alternatives

If you’re one of the millions of Americans taking the prescription medication Humira, get ready to add the word biosimilars to your conversations with your doctor.

Tribune News Service · Jun 30, 2023